The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
By J. Klastersky, M. Paesmans, E. Rubenstein, Michael Boyer, L. Elting, R. Feld, James J. Gallagher, J. Herrstedt, B. Rapoport, K. Rolston and 1 more. Journal of Clinical Oncology, 2000
1,093 citations recorded by the source corpus.
Subfields: Clinical Biochemistry, Molecular Medicine, Oncology
View Paper: https://www.semanticscholar.org/paper/8e47b5f45d6c093c25f4135a152e766eeb103efa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Naurois
- J. Klastersky
- L. Cosler
- M. Aapro
- K. Rolston
- B. Rapoport
- G. Maschmeyer
- J. Herrstedt
Citations in the corpus
- Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients (2006, methodology): “The Multinational Association of Supportive Care in Cancer has developed a model based on low-risk characteristics identified in 756 patients.(18) Independent predictive factors of favorable outcome in an episode of FN were low burden of illness, solid tumor, no previous fungal infection in patients”
- Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. (2010, background): “theoretical score is therefore 26 [2].”